Healthcare -
Biotechnology - NASDAQ - US
$ 1.83
-1.08 %
$ 399 M
Market Cap
-8.32
P/E
AKBA - COMMON STOCK
Common Stock AKBA - Akebia Therapeutics, Inc.
2 K
LAST VALUE
41.42%
2 YEAR CAGR
14.87%
5 YEAR CAGR
31.04%
10 YEAR CAGR